Medicines

For help on how to get the results you want, see our search tips.

Search results

2402 results

Sort by

List item

Perindopril: List of nationally authorised medicinal products - PSUSA/00002354/201510 (PDF/439.31 KB)

Last updated: 17/10/2016
Active substance: perindopril
Procedure number: PSUSA/00002354/201510
Regulatory outcome: Variation
List item

Hexoprenaline sulphate: List of nationally authorised products - PSUSA/00003170/201508 (PDF/129.67 KB)

Last updated: 17/10/2016
Active substance: hexoprenaline sulfate
Procedure number: PSUSA/00003170/201508
Regulatory outcome: Maintenance
List item

Human coagulation factor VIII (antihemophilic factor A): List of nationally authorised products - PSUSA/00001620/201411 (PDF/205.18 KB)

Last updated: 17/10/2016
Active substance: human coagulation factor VIII (antihemophilic factor A)
Procedure number: PSUSA/00001620/201411
Regulatory outcome: Maintenance
List item

Hexaminolevulinate hydrochloride: List of nationally authorised products - PSUSA/00001606/201409 (PDF/96.02 KB)

Last updated: 17/10/2016
Active substance: hexaminolevulinate hydrochloride
Procedure number: PSUSA/00001606/201409
Regulatory outcome: Maintenance
List item

Human anti-d immunoglobulin: List of nationally authorised products - PSUSA/00001614/201503 (PDF/99.95 KB)

Last updated: 17/10/2016
Active substance: human anti-d immunoglobulin
Procedure number: PSUSA/00001614/201503
Regulatory outcome: Maintenance
List item

Human coagulation factor VIII / human von Willebrand factor: List of nationally authorised products - PSUSA/00001621/201510 (PDF/128.56 KB)

Last updated: 17/10/2016
Active substance: Human coagulation factor VIII, human von willebrand factor
Procedure number: PSUSA/00001621/201510
Regulatory outcome: Maintenance
List item

Hydrochlorothiazide, ramipril: List of nationally authorised medicinal products - PSUSA/00001660/201501 (PDF/116.38 KB)

Last updated: 17/10/2016
Active substance: hydrochlorothiazide, Ramipril
Procedure number: PSUSA/00001660/201501
Regulatory outcome: Maintenance
List item

Hydrochlorothiazide, spironolactone: CMDh scientific conclusions and grounds for the variation, amendments to the product information and timetable for the implementation - PSUSA/00001662/201501 (PDF/1.53 MB)

Last updated: 17/10/2016
Active substance: hydrochlorothiazide, spironolactone
Procedure number: PSUSA/00001662/201501
Regulatory outcome: Variation
List item

Human fibrinogen: List of nationally authorised medicinal products - PSUSA/00001624/201506 (PDF/140.41 KB)

Last updated: 17/10/2016
Active substance: human fibrinogen
Procedure number: PSUSA/00001624/201506
Regulatory outcome: Maintenance
List item

Hydrochlorothiazide, spironolactone: List of nationally authorised medicinal products - PSUSA/00001662/201501 (PDF/63.12 KB)

Last updated: 17/10/2016
Active substance: hydrochlorothiazide, spironolactone
Procedure number: PSUSA/00001662/201501
Regulatory outcome: Variation
List item

Hydroxyzine chloride, hydroxyzine pamoate and all fixed combination/ hydroxyzine: List of nationally authorised medicinal products - PSUSA/00001696/201411 (PDF/79.44 KB)

Last updated: 17/10/2016
Active substance: hydroxyzine chloride, hydroxyzine pamoate, hydroxyzine
Procedure number: PSUSA/00001696/201411
Regulatory outcome: Maintenance
List item

Hydrochlorothiazide / lisinopril: List of nationally authorised medicinal products - PSUSA/00001654/201602 (PDF/96.95 KB)

Last updated: 17/10/2016
Active substance: hydrochlorothiazide, lisinopril
Procedure number: PSUSA/00001654/201602
Regulatory outcome: Maintenance
List item

Hydroxyethyl starch: List of nationally authorised medicinal products - PSUSA/00001694/201501 (PDF/146.48 KB)

Last updated: 17/10/2016
Active substance: hydroxyethyl starch
Procedure number: PSUSA/00001694/201501
Regulatory outcome: Maintenance
List item

Alanine / arginine / aspartic acid / cysteine / glucose anhydrous / glutamic acid / glycine / histidine / isoleucine / leucine / lysine / methionine / olive oil refined / ornithine / phenylalanine / proline / serine / so... (PDF/83.06 KB)

Last updated: 17/10/2016
Active substance: alanine, arginine, aspartic acid, cysteine, glucose anhydrous, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, ornithine, phenylalanine, proline, serine, sodium chloride, sodium glycerophosphate hydrated, soya bean oil, taurine, threonine, tryptophan, tyrosine, valine, potassium acetate, calcium chloride dihydrate, magnesium acetate tetrahydrate, olive oil
Procedure number: PSUSA/00010190/201506
Regulatory outcome: Maintenance
List item

Alanine / arginine / aspartic acid / cysteine / glucose anhydrous / glutamic acid / glycine / histidine / isoleucine / leucine / lysine / methionine / olive oil refined / ornithine / phenylalanine / proline / serine / so... (PDF/111.91 KB)

Last updated: 17/10/2016
Active substance: alanine, arginine, aspartic acid, cysteine, glucose anhydrous, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, ornithine, phenylalanine, proline, serine, sodium chloride, sodium glycerophosphate hydrated, soya bean oil, taurine, threonine, tryptophan, tyrosine, valine, potassium acetate, calcium chloride dihydrate, magnesium acetate tetrahydrate, olive oil
Procedure number: PSUSA/00010190/201512
Regulatory outcome: Maintenance
List item

Albendazole: List of nationally authorised medicinal products - PSUSA/00000073/201507 (PDF/86.37 KB)

Last updated: 17/10/2016
Active substance: albendazole
Procedure number: PSUSA/00000073/201507
Regulatory outcome: Maintenance
List item

Acitretin: List of nationally authorised medicinal products - PSUSA/00000051/201510 (PDF/84.93 KB)

Last updated: 17/10/2016
Active substance: acitretin
Procedure number: PSUSA/00000051/201510
Regulatory outcome: Variation
List item

Alendronate: List of nationally authorised medicinal products - PSUSA/00000078/201601 (PDF/375.08 KB)

Last updated: 17/10/2016
Active substance: alendronate
Procedure number: PSUSA/00000078/201601
Regulatory outcome: Maintenance
List item

Acitretin: CMDh scientific conclusions and grounds for the variation, amendments to the product information and timetable for the implementation- PSUSA/00000051/201510 (PDF/2.63 MB)

Last updated: 17/10/2016
Active substance: acitretin
Procedure number: PSUSA/00000051/201510
Regulatory outcome: Variation
List item

Alendronate / alfacalcidol: List of nationally authorised medicinal products - PSUSA/00010308/201512 (PDF/70.31 KB)

Last updated: 17/10/2016
Active substance: alendronate, alfacalcidol
Procedure number: PSUSA/00010308/201512
Regulatory outcome: Maintenance
List item

Acipimox: List of nationally authorised medicinal products - PSUSA/00000050/201512 (PDF/70.4 KB)

Last updated: 17/10/2016
Active substance: acipimox
Procedure number: PSUSA/00000050/201512
Regulatory outcome: Maintenance
List item

Aciclovir: List of nationally authorised medicinal products - PSUSA 00000048/201506 (PDF/209.86 KB)

Last updated: 17/10/2016
Active substance: Aciclovir
Procedure number: PSUSA 00000048/201506
Regulatory outcome: Maintenance
List item

Acetylsalicylic acid / bisoprolol: List of nationally authorised medicinal products - PSUSA/00010287/201511 (PDF/149.97 KB)

Last updated: 17/10/2016
Active substance: acetylsalicylic acid, bisoprolol
Procedure number: PSUSA/00010287/201511
Regulatory outcome: Maintenance
List item

Adapalene / benzoyl peroxide: List of nationally authorised medicinal products - PSUSA/00000059/201409 (PDF/96.86 KB)

Last updated: 17/10/2016
Active substance: adapalene, benzoyl peroxide
Procedure number: PSUSA/00000059/201409
Regulatory outcome: Maintenance
List item

Iloprost (iv solution): List of nationally authorised medicinal products - PSUSA/00009190/201501 (PDF/81.48 KB)

Last updated: 17/10/2016
Active substance: iloprost
Procedure number: PSUSA/00009190/201501
Regulatory outcome: Maintenance

2402 results

Perindopril: List of nationally authorised medicinal products - PSUSA/00002354/201510 (PDF/439.31 KB)

Hexoprenaline sulphate: List of nationally authorised products - PSUSA/00003170/201508 (PDF/129.67 KB)

Human coagulation factor VIII (antihemophilic factor A): List of nationally authorised products - PSUSA/00001620/201411 (PDF/205.18 KB)

Hexaminolevulinate hydrochloride: List of nationally authorised products - PSUSA/00001606/201409 (PDF/96.02 KB)

Human anti-d immunoglobulin: List of nationally authorised products - PSUSA/00001614/201503 (PDF/99.95 KB)

Human coagulation factor VIII / human von Willebrand factor: List of nationally authorised products - PSUSA/00001621/201510 (PDF/128.56 KB)

Hydrochlorothiazide, ramipril: List of nationally authorised medicinal products - PSUSA/00001660/201501 (PDF/116.38 KB)

Hydrochlorothiazide, spironolactone: CMDh scientific conclusions and grounds for the variation, amendments to the product information and timetable for the implementation - PSUSA/00001662/201501 (PDF/1.53 MB)

Human fibrinogen: List of nationally authorised medicinal products - PSUSA/00001624/201506 (PDF/140.41 KB)

Hydrochlorothiazide, spironolactone: List of nationally authorised medicinal products - PSUSA/00001662/201501 (PDF/63.12 KB)

Hydroxyzine chloride, hydroxyzine pamoate and all fixed combination/ hydroxyzine: List of nationally authorised medicinal products - PSUSA/00001696/201411 (PDF/79.44 KB)

Hydrochlorothiazide / lisinopril: List of nationally authorised medicinal products - PSUSA/00001654/201602 (PDF/96.95 KB)

Hydroxyethyl starch: List of nationally authorised medicinal products - PSUSA/00001694/201501 (PDF/146.48 KB)

Alanine / arginine / aspartic acid / cysteine / glucose anhydrous / glutamic acid / glycine / histidine / isoleucine / leucine / lysine / methionine / olive oil refined / ornithine / phenylalanine / proline / serine / so... (PDF/83.06 KB)

Alanine / arginine / aspartic acid / cysteine / glucose anhydrous / glutamic acid / glycine / histidine / isoleucine / leucine / lysine / methionine / olive oil refined / ornithine / phenylalanine / proline / serine / so... (PDF/111.91 KB)

Albendazole: List of nationally authorised medicinal products - PSUSA/00000073/201507 (PDF/86.37 KB)

Acitretin: List of nationally authorised medicinal products - PSUSA/00000051/201510 (PDF/84.93 KB)

Alendronate: List of nationally authorised medicinal products - PSUSA/00000078/201601 (PDF/375.08 KB)

Acitretin: CMDh scientific conclusions and grounds for the variation, amendments to the product information and timetable for the implementation- PSUSA/00000051/201510 (PDF/2.63 MB)

Alendronate / alfacalcidol: List of nationally authorised medicinal products - PSUSA/00010308/201512 (PDF/70.31 KB)

Acipimox: List of nationally authorised medicinal products - PSUSA/00000050/201512 (PDF/70.4 KB)

Aciclovir: List of nationally authorised medicinal products - PSUSA 00000048/201506 (PDF/209.86 KB)

Acetylsalicylic acid / bisoprolol: List of nationally authorised medicinal products - PSUSA/00010287/201511 (PDF/149.97 KB)

Adapalene / benzoyl peroxide: List of nationally authorised medicinal products - PSUSA/00000059/201409 (PDF/96.86 KB)

Iloprost (iv solution): List of nationally authorised medicinal products - PSUSA/00009190/201501 (PDF/81.48 KB)